AQMS
Aqua Metals, Inc.
There isn't enough reported data to score AQMS yet.
CAT
Caterpillar Inc.
CAT's fundamentals are strong, but it looks expensive: trading at 24x earnings, above its usual 18x. Analysts expect strong earnings growth, though they disagree widely on how much.
AQMS Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
AQMS's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
AQMS PE Valuation
AQMS has no meaningful PE right now: it lost money over the past year.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
AQMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong decline | |
| -- | |
| Limited | |
| High |
Analysts expect AQMS's losses to grow, with revenue declining.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
AQMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$9.21 | +$26.83 |
| Q1 2026 | -$15.34 | +$23.26 |
| Q4 2025 | -$24.42 | +$13.88 |
| Q3 2025 | -$30.63 | +$18.32 |
| Q2 2025 | -$36.04 | +$13.31 |
| Q1 2025 | -$38.60 | +$12.75 |
| Q4 2024 | -$38.30 | +$15.05 |
| Q3 2024 | -$48.95 | -$6.48 |
AQMS is still losing money, but far less than before: $9.21 per share over the past year, against $206.00 at its worst in late 2019.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the edge over AQMS on earnings quality, reporting a profit while its opponent remains loss making.
AQMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2020 | $90K | -96% |
CAT has the stronger quarterly revenue trend. Revenue is down 100% for AQMS versus up 17% for CAT.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2023 | -19796% | N/A |
| Q2 2022 | -98875% | N/A |
| Q4 2021 | -2428% | N/A |
| Q3 2020 | -3790% | -3313 points |
| Q1 2020 | -22572% | N/A |
| Q4 2019 | -1734% | N/A |
| Q3 2019 | -477% | N/A |
AQMS's operating margin was −19796% last quarter, up 2776 points from the same quarter a year ago.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT's revenue has grown year over year for five quarters in a row: $20.7B last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT's operating margin was 20% last quarter, up 3.1 points from the same quarter a year ago.
AQMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$2.6M | +$48K |
| Q1 2026 | -$3.8M | -$802K |
| Q4 2025 | -$2.6M | -$145K |
| Q3 2025 | -$2.3M | +$2.3M |
| Q2 2025 | -$2.7M | +$4.8M |
| Q1 2025 | -$3M | +$3.9M |
| Q4 2024 | -$2.5M | +$2.4M |
| Q3 2024 | -$4.6M | -$758K |
AQMS has burned cash in almost every quarter: −$11M over the past year, against −$13M the year before.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT has the edge over AQMS on cash generation, producing positive trailing cash flow while its opponent burns cash.
AQMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +5.3% | +172K shares |
| 1 year | +321% | +2.6M shares |
| 3 years | +799% | +3M shares |
| 5 years | +997% | +3.1M shares |
| Available history | +1095% | +3.1M shares |
AQMS has 3M diluted shares, up 321% from a year ago.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over AQMS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
AQMS Net Leverage
AQMS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has more cash than debt.
AQMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.8 | Neutral |
| Stochastic | 11.6 | Oversold |
AQMS's weekly RSI is 32 (neutral) and its Stochastic is 12 (oversold).
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
AQMS PE vs Industrials Sector
AQMS has no meaningful PE right now: it lost money over the past year.
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
AQMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.77 | 23% below |
| 20 week MA | $2.32 | 41% below |
| 50 week MA | $3.70 | 63% below |
| 100 week MA | $7.76 | 82% below |
| 200 week MA | $75.2 | 98% below |
AQMS is in a downtrend: it's below all five of its weekly moving averages, and 98% below its 200-week average.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has the edge over AQMS on trend strength, trading above more of its moving averages.
AQMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $166.0 | $468.0 | +182% |
| 2021 | $468.0 | $276.0 | -41% |
| 2022 | $276.0 | $148.0 | -46% |
| 2023 | $148.0 | $152.0 | +2.7% |
| 2024 | $152.0 | $26.2 | -83% |
| 2025 | $26.2 | $4.85 | -81% |
| 2026 YTD | $4.85 | $1.37 | -72% |
AQMS's yearly returns have swung widely, from +182% in 2020 to −83% in 2024. It's down 72% so far in 2026.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has the edge over AQMS on returns for 2026, with the stronger performance.